4//SEC Filing
Pivotal bioVenture Partners Fund I, L.P. 4
Accession 0001012975-20-000601
CIK 0001722271other
Filed
Jun 30, 8:00 PM ET
Accepted
Jul 1, 4:14 PM ET
Size
11.1 KB
Accession
0001012975-20-000601
Insider Transaction Report
Form 4
Akouos, Inc.AKUS
Transactions
- Conversion
Common Stock
2020-06-30+1,499,971→ 1,499,971 total(indirect: See footnote) - Purchase
Common Stock
2020-06-30$17.00/sh+294,117$4,999,989→ 1,794,088 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2020-06-30−1,499,971→ 0 total(indirect: See footnote)→ Common Stock (1,499,971 underlying)
Transactions
- Conversion
Common Stock
2020-06-30+1,499,971→ 1,499,971 total(indirect: See footnote) - Purchase
Common Stock
2020-06-30$17.00/sh+294,117$4,999,989→ 1,794,088 total(indirect: See footnote) - Conversion
Series B Preferred Stock
2020-06-30−1,499,971→ 0 total(indirect: See footnote)→ Common Stock (1,499,971 underlying)
Footnotes (2)
- [F1]On June 30, 2020, the Series B Preferred Stock converted into Common Stock on a 21.073-for-1 basis upon the closing of the Issuer's initial public offering without payment of consideration. The Series B Preferred Stock was convertible at any time at the holder's election and automatically upon the closing of the Issuer's initial public offering. The shares had no expiration date.
- [F2]The reportable securities are owned directly by Pivotal bioVenture Partners Fund I, L.P. ("Pivotal"). The general partner of Pivotal is Pivotal bioVenture Partners Fund I G.P., L.P., or Pivotal GP. Robert Hopfner, Vincent Cheung, Peter Bisgaard, and Heather Preston are the managing partners of Pivotal and may be deemed to have shared voting and dispositive power over the shares owned by Pivotal.
Documents
Issuer
Akouos, Inc.
CIK 0001722271
Entity typeother
IncorporatedCayman Islands
Related Parties
1- filerCIK 0001695076
Filing Metadata
- Form type
- 4
- Filed
- Jun 30, 8:00 PM ET
- Accepted
- Jul 1, 4:14 PM ET
- Size
- 11.1 KB